The Biologic’s Path to Clinic

Reading Time: < 1 minute Custom content for Catalent

Reading Time: < 1 minute

Custom content for Catalent by BioPharma Dive’s Brand Studio

The cost and complexity of commercializing a biologic drug can be daunting, especially when it’s estimated that nine out of 10 drugs in clinical trials do not make it to market. While the path to (and through) clinical trials can be a complicated and challenging process, your team doesn’t need to face the burden of costs, time and other obstacles on their own.

Download our new interactive infographic to learn more about how CDMOs can help in navigating the complex clinic process.


Debra Bruce

Debra Bruce is an experienced “Tech-Blogger” and a proven marketer. She has expertise across topics like artificial intelligence, virtual reality, marketing technologies, and big data technologies. She has a good rapport with her readers and her insights are quite well received by her peers. She has completed her Masters’ in marketing management from California State University, Fullerton. She is currently working as Vice-president marketing communications for KnowledgeNile.

About Debra Bruce

Debra Bruce is an experienced “Tech-Blogger” and a proven marketer. She has expertise across topics like artificial intelligence, virtual reality, marketing technologies, and big data technologies. She has a good rapport with her readers and her insights are quite well received by her peers. She has completed her Masters’ in marketing management from California State University, Fullerton. She is currently working as Vice-president marketing communications for KnowledgeNile.